We Need to Talk About CRISPR
By Staff,
The Medicine Maker
| 03. 21. 2025
"The Promise and Peril of CRISPR" cover by Johns Hopkins University Press
As a paediatrician taking care of children with sickle cell disease, Neal Baer, a Harvard Medical School graduate, was in awe of the power of CRISPR technologies. Later becoming a TV show writer (for hit shows such as ER, Law and Order, and Under the Dome), Baer realized that the promise of advanced medicine could quickly become a peril, if placed in the wrong hands. This inspired him to compile a collection of essays that asks how far could – or should – humanity develop it. The Promise and the Peril of CRISPR chronicles the human condition in the 21st century, and asks what is more valuable: saving lives, or wielding power? Here he discusses the duality of CRISPR.
What inspired you to compile a collection of essays about CRISPR specifically?
There are lots of reasons. It’s important to know who has access to the data, and the DNA. Is it safe? What are the unforeseen consequences? Will there still be problems once one piece of DNA...
Related Articles
By Rob Stein, NPR [cites CGS' Katie Hasson] | 08.06.2025
A Chinese scientist horrified the world in 2018 when he revealed he had secretly engineered the birth of the world's first gene-edited babies.
His work was reviled as reckless and unethical because, among other reasons, gene-editing was so new...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...
By Keith Casebonne and Jodi Beckstine [with CGS' Katie Hasson], Disability Deep Dive | 07.24.2025
In this episode of Disability Deep Dive, hosts Keith and Jodi explore the complex interplay between disability science, technology, and ethics with guest Katie Hasson, Associate Director at the Center for Genetics and Society. The conversation delves into...